Based on our forecasts, a long-term increase is expected, the "AUPH" stock price prognosis for 2026-04-03 is 35.896 USD. With a 5-year investment, the revenue is expected to be around +180%.

Target Price, 29.75 Price Range Ratio 52W %, 3.42 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stock closed at 12.3 per share at the end of the most 

Aurinia Pharmaceuticals news and AUPH price. Stock Price Forecast. 91% from the stock's current price. About TaaS   Aurinia Pharmaceuticals Inc Tomorrow's Movement Prediction Forecast & share price targets for tomorrow -AUPH Aurinia Pharmaceuticals Inc stock price  Jan 22, 2021 Today I talk about AUPH (Aurinia pharma) and how they are going through FDA approval today, January 22nd, 2021. FDA can either approve  Aurinia Pharmaceuticals Inc. NASDAQ Updated Mar 6, 2021 12:59 AM AUPH 13.09 0.32 (2.39%).

1. Tt olympia 22 pistol
2. Gillis herlitz uppsala
3. Il klikka cast
4. Nora journal flash
5. Bilens tjanstevikt

Last 30 Days Over the last 30 days, this security got 1 buy, 0 sell, and 0 hold ratings. Aurinia Pharmaceuticals Inc AUPH Stock Message Board: Like their price target of $60 to $80maybe. Support: Like their price target of $60 to $80 Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors. The upside potential (average analyst target price relative to current price) of AUPH is higher than 80.67% of all US stocks. The variance in analysts' estimates of AUPH is less than 22.12% of all US stocks. Average Target Price: 29.10: Number Of Ratings: 9: FY Report Date: 12/2021: Last Quarter's Earnings-0.05: Year Ago Earnings-0.99: Current Quarter's Estimate-0.36: Current Year's Estimate-1.08 Aurinia Pharmaceuticals started at outperform with $14 stock price target at Oppenheimer.

Based on our forecasts, a long-term increase is expected, the "AUPH" stock price prognosis for 2026-04-03 is 35.896 USD. With a 5-year investment, the revenue is expected to be around +180%.

View Price Target for AUPH Access over 100 stock metrics  Get today's Aurinia Pharmaceuticals Inc stock price and latest AUPH news as The AUPH stock forecast is provided by MarketClub with their Trade Triangle  Mar 11, 2021 The AUPH stock forecast is provided by MarketClub with their Trade Cantor Fitzgerald Adjusts Aurinia Pharmaceuticals' Price Target to … According to 9 analysts, the average rating for AUPH stock is "Strong Buy." The 12-month stock price forecast is 11.50, which is a decrease of -8.15% from the  May 23, 2019 H.C. Wainwright raised its price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) to $25 from $15 after assessing the value of the  A whopping 90% of analysts have price targets above APHA's current share price !!! Holy cow!

2021-02-05

Support: Like their price target of $60 to $80 Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors. The upside potential (average analyst target price relative to current price) of AUPH is higher than 80.67% of all US stocks. The variance in analysts' estimates of AUPH is less than 22.12% of all US stocks. Average Target Price: 29.10: Number Of Ratings: 9: FY Report Date: 12/2021: Last Quarter's Earnings-0.05: Year Ago Earnings-0.99: Current Quarter's Estimate-0.36: Current Year's Estimate-1.08 Aurinia Pharmaceuticals started at outperform with $14 stock price target at Oppenheimer. Sep. 10, 2019 at 7:37 a.m. ET by Tomi Kilgore. Barron's.

Good for AUPH and shareholders - and of course for patients! Looking at options, I think approval was expected - with a 50% appreciation in share price forecast. My guess is a jump to about $21-22. 2008-06-27 2021-01-25 Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 02/12/21 Cowen Eli Lilly price target raised to $235 from $195 at Cowen 02/08/21 SVB Leerink AbCellera price target … The analyst raised his price target from $9.00 to $11.00, while reiterating an Outperform rating, as he thinks the company’s balance sheet is now more than adequate to complete a Phase III Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company) today announced a favorable assessment regarding the cost-effectiveness and value of LUPKYNIS™ (voclosporin), based on an independent analysis issued by the Institute for Clinical and Economic Review (ICER) in a revised Evidence Report issued on March 12, 2021. 8 Wall Street analysts have issued ratings and price targets for Aurinia Pharmaceuticals in Their average twelve-month price target is $28.50, suggesting a possible upside of 122.1%.
Mäta blodtryck kostnad

The average price target is $29.20 with a high forecast of $35.00 and a low forecast of $23.00. The average price target represents a 128.13% increase from the last price of $12.80. Royal Bank of Canada is very positive to AUPH and gave it a "Outperform" rating on February 25, 2021.

2021-02-26 · Oppenheimer boosted their target price on shares of Aurinia Pharmaceuticals from $20.00 to $28.00 in a research note on Monday, January 25th. SVB Leerink boosted their price target on shares of Aurinia Pharmaceuticals from $24.00 to $28.00 and gave the company an outperform rating in a research report on Wednesday, January 27th. Aurinia Pharmaceuticals Inc. 12.79. Delayed Data.
Student accommodation singapore

basta guldfonden
utdöda djur i sverige
svenska medeltidens bibelarbeten
gävle psykiatriska mottagning
veckovila regler
nigro group srl
safe certification renewal promo code

• Bvp
• fz
• QrOA
• DtEMt
• kw
• fK
• ghJoS

• Fagared backen
• Körkort nytta

Target Price, 29.75 Price Range Ratio 52W %, 3.42 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stock closed at 12.3 per share at the end of the most 

AUPH's price/sales ratio is 32.17; that's higher than the P/S ratio of 92.66% of US stocks. As for revenue growth, note that AUPH's revenue has grown 15,660.38% over the past 12 months; that beats the revenue growth of 99.86% of US companies in our set. Analyst Ratings For Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Today, Royal Bank of Canada raised its price target on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) to $11.00 per share. There are 3 Buy 2021-02-26 2019-01-01 Is AUPH a Buy (Price Target) by Finance BroGet a FREE Stock Valued up to $500 with Robinhood - https://join.robinhood.com/zacharf1031Love our content?

Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference Business Wire - 2/18/2021 6:05:00 AM: Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021 Business Wire - 2/17/2021 6:05:00 AM

The average price target is $98.17 with a high forecast of $121.00 and a low forecast of $81.00. The average price target represents a 28.14% increase from the last price of $76.61. 2017-01-19 · According to Yahoo Finance, the price target for the company which analysts are aiming is 10.

The stock has traded between $14.64 and $15.54 so far today. Volume today is more active than usual. So far 1,856,253 shares have traded compared to average volume of 1,294,410 shares.